United Biomedical Inc. of Hauppauge, N.Y., has receivedapproval from the Ministry of Health of the People's Republicof China to begin clinical trials of its prototype synthetic AIDSvaccine. The trial, which will be in Yunnan Province, willevaluate the safety and immune-stimulating capacity of thevaccine in volunteers at high risk for HIV infection.Epidemiological investigations conducted by the ChineseAcademy of Preventive Medicine confirmed a high prevalenceof HIV infection among intravenous drug users in the Chineseprovince.

(c) 1997 American Health Consultants. All rights reserved.